
New Machine Learning Model Predicts Who Will Develop Diabetes
Researchers created a machine-learning–based model to help predict which patients will develop diabetes, according to an abstract to be published in the Journal of the Endocrine Society.
Researchers created a machine-learning—based model to help predict which patients will develop
“Currently, we do not have sufficient methods for predicting which generally healthy individuals will develop diabetes,"
The artificial intelligence (AI) was created via a retrospective analysis of 509,153 annual specific health checkup records from 139,225 patients. In addition, 65,505 patients without diabetes mellitus (DM) were included in the dataset.
Gradient-boosting decision trees were used to identify DM signatures prior to the onset of the disease in patients. Between 2008 and 2018, the researchers collected a variety of records from patients in Kanazawa city, Ishikawa, Japan. The data included results of physical examinations and blood and urine tests, as well as questionnaires completed by study participants.
“Machine learning is a type of AI that enables computers to learn without being explicitly programmed,” according to the
The researchers divided the dataset into a 6:2:2 ratio in order to first train the AI, then tune it by internal validation, and then to test the model. To determine the model’s accuracy, they evaluated its ability to calculate area under the curve (AUC), its overall precision, recall, and
The training dataset included 36,303 participants, while the testing and tuning datasets consisted of 13,101 participants each.
During the study period, the researchers identified 4696 (97.2%) patients with new-onset DM. They found the trained model “predicted the future incidence of DM, with the AUC, precision, recall, F1 score, and overall accuracy [measuring at] 0.71 (95% CI, 0.69-0.72), 75.3% (71.6%-78.8%), 42.2% (39.3%-45.2%), 54.1% (51.2%-56.7%), and 94.9% (94.5%-95.2%), respectively.”
Machine learning could enable healthcare systems to precisely identify groups at high risk for developing diabetes and lead to effective intervention strategies.
In the future, the researchers plan to perform clinical trials “to assess the effectiveness of using statins to treat groups of patients identified by the machine learning model as being at high risk of developing diabetes.”
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.